• Categories:

    Appointment of Malte Peters as EORTC Strategic Alliance Officer

    9 Feb 2024

  • EORTC EMA workshops
    Categories: ,

    Unique series of workshops in partnership with the European Medicines Agency (EMA)

    7 Feb 2024

  • Ravina-Trial
    Categories: ,

    EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

    14 Dec 2023

  • IMMUcan abstracts at ESMO Immuno-Oncology 2023
    Categories: , , ,

    Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

    6 Dec 2023

  • EORTC Quality of Life measures integrated in CDISC
    Categories: ,

    EORTC Quality of Life measures integrated in CDISC

    20 Nov 2023

  • ATOM study
    Categories: ,

    EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

    7 Nov 2023

  • acute myeloid leukaemia publication
    Categories: ,

    Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

    31 Oct 2023

  • ESMO 2023 Madrid
    Categories: , , ,

    New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023

    20 Oct 2023